Quantcast
Last updated on April 18, 2014 at 10:16 EDT

Latest Diagnostic Information Services Stories

2014-04-07 12:29:18

Company launches new website to enable patients to access lab data under federal rule that takes effect today MADISON, N.J., April 7, 2014 /PRNewswire/ -- For the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. Quest Diagnostics provides diagnostic information services to about 30% of American adults each year....

2014-03-10 08:29:15

- Full Year 2014 Revenues expected to grow 2% - 4% compared to 2013 MADISON, N.J., March 10, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously announced acquisition of Solstas Lab Partners Group and its subsidiaries (Solstas), a full-service commercial laboratory company based in Greensboro, North Carolina. The combination of Solstas with Quest Diagnostics will give patients...

2014-02-26 08:29:58

Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3 MADISON, N.J., Feb. 26, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced new pathology and blood test offerings to help identify and assess an individual's risk of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), an inherited...

2014-01-22 08:29:22

Transaction to give patients and healthcare providers in the Southeastern United States greater access to innovative and cost-effective diagnostic information services MADISON, N.J., Jan. 22, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries (Solstas) for a total transaction...

2014-01-09 12:27:03

MADISON, N.J. and SAN FRANCISCO, Jan. 9, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the University of California, San Francisco (UCSF), the nation's leading university focused exclusively on health, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine, for improved patient care, treatment and outcomes. Initial clinical...

2013-12-09 12:25:53

Quest and Alamo Breast Cancer Foundation also Co-Hosting Panel on "Cancer and BRCA Testing in the News, the Arts and Popular Culture," Joined by Director of Upcoming Film "Decoding Annie Parker" MADISON, N.J., Dec. 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that BRCAvantage(TM), a service-rich oncology offering designed to increase access to BRCA testing for at-risk patients and maximize the value...

2013-10-15 08:33:34

Also Releases Results from National Harris Survey Revealing Widespread Confusion about BRCA Testing MADISON, N.J., Oct. 15, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of BRCAvantage(TM), a suite of four new lab-developed genetic tests (LDT) that identify mutations in BRCA1 and BRCA2 genes, which are associated with increased risk of inherited breast and ovarian cancers. Serving...

2013-10-07 20:22:35

CHICAGO, Oct. 7, 2013 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has sold ConVerge Diagnostic Services to Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. Headquartered in Peabody, Mass, ConVerge is a leading full-service regional laboratory providing clinical, cytology and anatomic pathology testing services. Water Street invested in...

2013-10-07 20:22:32

Transaction to expand patient access to innovative diagnostic information services and bolster Quest's growth strategy in New England MADISON, N.J. and PEABODY, Mass., Oct. 7, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired ConVerge Diagnostic Services, LLC from Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry. ConVerge is a...

2013-07-18 08:28:53

Retains royalty rights to odanacatib and other Celera drug assets MADISON, N.J. and NEW YORK, July 18, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products,...